Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2007

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 6-7, 2008, Pages 451-461

  Naver, Lars ^a   Bohlin, Ann Britt ^a   Albert, Jan ^b,c   Flamholc, Leo ^d   Gisslen, Magnus ^e   Gyllensten, Katarina ^a   Josephson, Filip ^a   Pehrson, Pehrolov ^a   Sonnerborg, Anders ^a   Westling, Katarina ^a   Lindgren, Susanne ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR PHOSPHATE; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; ATAZANAVIR; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; DARUNAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ENFUVIRTIDE; ETRAVIRINE; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; MARAVIROC; NEVIRAPINE; PROTEINASE INHIBITOR; RALTEGRAVIR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; VIRUS DNA; ZIDOVUDINE;

ADD ON THERAPY; ANEMIA; ANTIBIOTIC PROPHYLAXIS; BILIRUBIN BLOOD LEVEL; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CESAREAN SECTION; COMBINATION CHEMOTHERAPY; DRESS SYNDROME; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE INCREASE; DRUG FORMULATION; DRUG HALF LIFE; DRUG TREATMENT FAILURE; FATIGUE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HIV EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYPOSPADIAS; INFECTION PREVENTION; LACTIC ACIDOSIS; LOADING DRUG DOSE; MONOTHERAPY; NEUROLOGIC DISEASE; NONHUMAN; PLACENTAL TRANSFER; PRACTICE GUIDELINE; PREGNANCY; PRENATAL DRUG EXPOSURE; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SWEDEN; TERATOGENICITY; VERTICAL TRANSMISSION; VIREMIA; VIRUS LOAD; VIRUS RESISTANCE; VIRUS TRANSMISSION;

ANTI-RETROVIRAL AGENTS; CESAREAN SECTION; CHEMOPREVENTION; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SWEDEN;

EID: 47349104088     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540801894787     Document Type: Review

References (27)

1. UNAIDS, WHO
2. Coovadia, HM, Rollins, NC, Bland, RM, Little, K., Coutsoudis, A. Bennish, ML et al. (2007) Mother-to-child transmission of HIV-1 infection during exclusive breast-feeding in the first 6 months of life: an intervention cohort study. Lancet, 369, pp. 1107-1116.
3. Mofenson, LM, Lambert, JS, Stiehm, ER, Bethel, J., Meyer, WA III Whitehouse, J. et al. (1999) Risk factors for perinatal transmission of human immunodeficiency virus type-1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med, 341, pp. 385-393.
4. Mandelbrot, L., Mayaux, MJ, Bongain, A., Berrebi, A., Moudoub-Jeanpetit, Y. Benifla, JL et al. (1996) Obstetric factors and mother-to-child transmission of human immunodeficiency virus type-1: The French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group. Am J Obstet Gynecol, 175, pp. 661-667.
5. O'Donovan, D., Ariyoshi, K., Milligan, P., Ota, M., Yamuah, L. Sarge-Njie, R. et al. (2000) Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. AIDS, 14, pp. 441-448.
6. The International Perinatal HIV Group (1999) The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type-1: A meta-analysis of 15 prospective cohort studies. N Engl J Med, 340, pp. 977-987.
7. European Collaborative Study (2005) Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. CID, 40, pp. 458-465.
8. Ioannidis, JP, Tatsioni, A., Abrams, EJ, Bulterys, M., Coombs, RW Goedert, JJ et al. (2004) Maternal viral load and rate of disease progression among vertically HIV-1-infected children: An international meta-analysis. AIDS, 18, pp. 99-108.
9. Naver, L., Lindgren, S., Belfrage, E., Gyllensten, K., Lidman, K. Gisslen, M. et al. (2006) Children born to HIV-1-infected women in Sweden in 1982-2003: Trends in epidemiology and vertical transmission. J Acquir Immune Defic Syndr, 42, pp. 484-489.
10. Kourtis, AP, Schmid, CH, Jamieson, DJ and Lau, J. (2007) Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: A meta-analysis. AIDS, 21, pp. 607-615.
11. Josephson, F., Albert, J., Flamholc, L., Gisslen, M., Karlstrom, O. Lindgren, SR et al. (2007) Antiretroviral treatment of HIV infection: Swedish recommendations 2007. Scand J Infect Dis, 39, pp. 486-507.
12. Jourdain, G., Ngo-Giang-Huong, N., Le Coeur, S, Bowonwatanuwong, C., Kantipong, P. Leechanachai, P. et al. (2004) Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med, 351, pp. 229-240.
13. Mirochnick, M., Stek, A., Acevedo, M., Keller, M., Holland, D. Capparelli, E. et al. (2005) Safety and pharmacokinetics of nelfinavir coadministered with zidovudine and lamivudine in infants during the first 6 weeks of life. J Acquir Immune Defic Syndr, 39, pp. 189-194.
14. Ripamonti, D., Cattaneo, D., Maggiolo, F., Airoldi, M., Frigerio, L. Bertuletti, P. et al. (2007) Atazanavir plus low-dose ritonavir in pregnancy: Pharmacokinetics and placental transfer. AIDS, 21, pp. 2409-2415.
15. Stek, AM, Mirochnick, M., Capparelli, E., Best, BM, Hu, C. Burchett, SK et al. (2006) Reduced lopinavir exposure during pregnancy. AIDS, 20, pp. 1931-1939.
16. Boffito, M., Arnaudo, I., Raiteri, R., Bonora, S., Sinicco, A. Di Garbo, A et al. (2002) Clinical use of lopinavir/ritonavir in a salvage therapy setting: Pharmacokinetics and pharmacodynamics. AIDS, 16, pp. 2081-2083.
17. Gonzalez de Requena, D, Gallego, O., Corral, A., Jimenez-Nacher, I. and Soriano, V. (2004) Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations. AIDS, 18, pp. 2091-2094.
18. The Antiretroviral Pregnancy Registry (2007)
19. Watts, DH, Li, D., Handelsman, E., Tilson, H., Paul, M. Foca, M. et al. (2007) Assessment of birth defects according to maternal therapy among infants in the Women and Infants Transmission Study. J Acquir Immune Defic Syndr, 44, pp. 299-305.
20. Barret, B., Tardieu, M., Rustin, P., Lacroix, C., Chabrol, B. Desguerre, I. et al. (2003) Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: Clinical screening in a large prospective cohort. AIDS, 17, pp. 1769-1785.
21. European Collaborative Study (2003) Exposure to antiretroviral therapy in utero or early life: The health of uninfected children born to HIV-infected women. J Acquir Immune Defic Syndr, 32, pp. 380-387.
22. The Perinatal Safety Review Working Group (2000) Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 y of age in 5 United States cohorts. J Acquir Immune Defic Syndr, 25, pp. 261-268.
23. Somigliana, E., Bucceri, AM, Tibaldi, C., Alberico, S., Ravizza, M. Savasi, V. et al. (2005) Early invasive diagnostic techniques in pregnant women who are infected with the HIV: A multicentre case series. Am J Obstet Gynecol, 193, pp. 437-442.
24. Coll, O., Suy, A., Hernandez, S., Pisa, S., Lonca, M. Thorne, C. et al. (2006) Prenatal diagnosis in human immunodeficiency virus-infected women: A new screening programme for chromosomal anomalies. Am J Obstet Gynecol, 194, pp. 192-198.
25. Public Health Service Task Force Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
26. Lallemant, M., Jourdain, G., Le Coeur, S, Mary, JY, Ngo-Giang-Huong, N. Koetsawang, S. et al. (2004) Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med, 351, pp. 217-228.
27. Hitti, J., Frenkel, LM, Stek, AM, Nachman, SA, Baker, D. Gonzalez-Garcia, A. et al. (2004) Maternal toxicity with continuous nevirapine in pregnancy: Results from PACTG 1022. J Acquir Immune Defic Syndr, 36, pp. 772-776.